More about

Prostate Cancer

News
September 19, 2023
2 min read
Save

Black men less likely to receive targeted therapy for metastatic prostate cancer

Black men less likely to receive targeted therapy for metastatic prostate cancer

Black men with metastatic castration-resistant prostate cancer appear less likely to receive targeted therapies than white men, according to data published in JAMA Network Open.

News
September 12, 2023
2 min watch
Save

VIDEO: Combo therapy improves outcomes for Black patients with metastatic prostate cancer

VIDEO: Combo therapy improves outcomes for Black patients with metastatic prostate cancer

CHICAGO — In this Healio video exclusive, Andrew Armstrong, MD, discusses the results of the use of abiraterone acetate and apalutamide plus prednisone in Black and White patients with metastatic castrate-resistant prostate cancer.

News
September 12, 2023
3 min watch
Save

VIDEO: ‘Practice-changing’ AI-derived biomarker can tailor ADT in high-risk prostate cancer

VIDEO: ‘Practice-changing’ AI-derived biomarker can tailor ADT in high-risk prostate cancer

CHICAGO — In this Healio video exclusive, Andrew Armstrong, MD, discusses his presentation from the Genitourinary Cancer session at the ASCO Annual meeting.

News
September 12, 2023
3 min watch
Save

VIDEO: Local radiotherapy benefits quality of life, not OS, in certain prostate cancers

VIDEO: Local radiotherapy benefits quality of life, not OS, in certain prostate cancers

CHICAGO — In this Healio video exclusive, Silke Gillessen, MD, discusses a study that confirms the triplet combination in de novo, low-volume, metastatic, castration-sensitive prostate cancer as the best course of action.

News
August 31, 2023
2 min read
Save

Half of men with metastatic prostate cancer face treatment-related financial toxicity

Half of men with metastatic prostate cancer face treatment-related financial toxicity

More than half of men treated for metastatic prostate cancer reported experiencing some degree of financial hardship, according to study results published in The Journal of Urology.

News
August 25, 2023
4 min read
Save

Biomarkers may predict risk for advanced prostate cancer among Black men

Biomarkers may predict risk for advanced prostate cancer among Black men

Researchers have discovered a biological mechanism among men with diabetes and metastatic prostate cancer that they believe may lay the foundation for better testing and treatments for Black men with both diseases.

News
August 24, 2023
2 min read
Save

Shared decision-making improves equitable prostate cancer screening

Shared decision-making improves equitable prostate cancer screening

Shared decision-making could attenuate racial disparities in prostate cancer screening, according to research published in the American Journal of Preventive Medicine.

News
August 23, 2023
5 min read
Save

Data confirm safety of active surveillance among patients with low-risk prostate cancer

Data confirm safety of active surveillance among patients with low-risk prostate cancer

Prostate cancer is a complex cancer, with patients who present differently with various clinical staging and criteria; thus, follow-up care after treatment also differs among this patient population.

News
August 21, 2023
1 min read
Save

Cabozantinib-atezolizumab combination extends PFS in metastatic prostate cancer

Cabozantinib-atezolizumab combination extends PFS in metastatic prostate cancer

The combination of cabozantinib and atezolizumab prolonged PFS compared with second novel hormonal therapy for men with metastatic castration-resistant prostate cancer, according to a topline data announcement.

News
August 15, 2023
2 min watch
Save

VIDEO: Treatment intensification in metastatic prostate cancer ‘underutilized’

VIDEO: Treatment intensification in metastatic prostate cancer ‘underutilized’

CHICAGO — In this video, Stephen J. Freedland, MD, discusses how intensification of androgen deprivation therapy using novel hormonal therapies remains underutilized in patients with de novo metastatic castration-sensitive prostate cancer.

View more